CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Anthony Iacovone

Cofounder, AdTheorent

Search every verified Anthony Iacovone interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Anthony Iacovone, cofounder of AdTheorent and CEO of BioSymetrics, discussed biomedical artificial intelligence and machine learning on The Business of Healthcare Podcast in October 2023. He stated that data preparation is more critical than algorithms in machine learning, describing it as a significant factor in model success or failure, particularly in healthcare where decisions affect diagnosis and drug discovery. He said his company has developed technology to methodically bring in data, and he expressed optimism that AI applied correctly could bring certain cures within reach over the next decade. He also noted an opportunity for machine learning to positively affect value-based care by integrating underused data across payers, hospital systems, and clinical settings. In a 2013 interview at Advertising Week, Iacovone, then CEO of AdTheorent, described the company as a second-generation mobile ad network using predictive modeling technology to make informed decisions before serving impressions. He distinguished predictive advertising from behavioral targeting by explaining that predictive methods incorporate variables such as ambient conditions, page sentiment, and socio-economic factors, rather than relying solely on user behavior frequency. He also commented on the challenge of data silos within agencies, where shopper marketing and media teams often fail to share data, and suggested that increased collaboration could improve advertising effectiveness.

Recent appearances

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →